| 000 | 02792 a2200757 4500 | ||
|---|---|---|---|
| 005 | 20250516140309.0 | ||
| 264 | 0 | _c20130426 | |
| 008 | 201304s 0 0 eng d | ||
| 022 | _a1529-2401 | ||
| 024 | 7 |
_a10.1523/JNEUROSCI.3585-12.2013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLloyd-Burton, Samantha M | |
| 245 | 0 | 0 |
_aSPARC regulates microgliosis and functional recovery following cortical ischemia. _h[electronic resource] |
| 260 |
_bThe Journal of neuroscience : the official journal of the Society for Neuroscience _cMar 2013 |
||
| 300 |
_a4468-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Newborn |
| 650 | 0 | 4 |
_aBrain Infarction _xetiology |
| 650 | 0 | 4 |
_aBrain Ischemia _xcomplications |
| 650 | 0 | 4 | _aCX3C Chemokine Receptor 1 |
| 650 | 0 | 4 |
_aCalcium-Binding Proteins _xmetabolism |
| 650 | 0 | 4 | _aCell Count |
| 650 | 0 | 4 |
_aCell Movement _xdrug effects |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aCell Size |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCerebral Cortex _xpathology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Agonists _xtoxicity |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aForelimb _xphysiopathology |
| 650 | 0 | 4 |
_aGalectin 3 _xmetabolism |
| 650 | 0 | 4 |
_aGene Expression Regulation, Developmental _xdrug effects |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aGlial Fibrillary Acidic Protein _xmetabolism |
| 650 | 0 | 4 |
_aGliosis _xetiology |
| 650 | 0 | 4 |
_aGlycoproteins _xdeficiency |
| 650 | 0 | 4 |
_aGreen Fluorescent Proteins _xgenetics |
| 650 | 0 | 4 |
_aIntracranial Thrombosis _xcomplications |
| 650 | 0 | 4 |
_aLectins _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aMicrofilament Proteins _xmetabolism |
| 650 | 0 | 4 |
_aMicroglia _xdrug effects |
| 650 | 0 | 4 |
_aMotor Skills _xdrug effects |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 |
_aN-Methylaspartate _xtoxicity |
| 650 | 0 | 4 |
_aOlfactory Bulb _xinjuries |
| 650 | 0 | 4 | _aOsteonectin |
| 650 | 0 | 4 |
_aProliferating Cell Nuclear Antigen _xmetabolism |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Chemokine _xgenetics |
| 650 | 0 | 4 |
_aRecovery of Function _xphysiology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xdeficiency |
| 650 | 0 | 4 | _aNF-kappaB-Inducing Kinase |
| 700 | 1 | _aYork, Elisa M | |
| 700 | 1 | _aAnwar, Mohammad A | |
| 700 | 1 | _aVincent, Adele J | |
| 700 | 1 | _aRoskams, A Jane | |
| 773 | 0 |
_tThe Journal of neuroscience : the official journal of the Society for Neuroscience _gvol. 33 _gno. 10 _gp. 4468-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1523/JNEUROSCI.3585-12.2013 _zAvailable from publisher's website |
| 999 |
_c22559657 _d22559657 |
||